Gareth Hicks Email
Co-founder, CEO and Board Member
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Gareth Hicks Location
- United States
Gareth Hicks Work
- 2024 -now Co-founder, CEO and Board Member @ Nocicera Therapeutics
- 2020 -now Co-founder, CSO and Board Member @ Severn Therapeutics
- 2017 -now Co-founder, Board Member and ad-interim CEO @ Endosome Therapeutics
- 2024 -2024 Entrepreneur in Residence @
- 2014 -2023 Vice President and Head Gastrointestinal Drug Discovery Unit @
- 2011 -2014 Chief Scientific Officer and Head of Scientific and Clinical Affairs @ Tioga Pharmaceuticals, Inc.
- 2008 -2011 Search and Evaluation, Business Development @
- 2007 -2008 Head Neuroscience Medical Affairs, Novartis Pharmaceuticals Corporation @
- 2006 -2007 Head, Gastroenterology and Urology Clinical Development and Medical Affairs, Novartis Pharmaceuticals Co @
- 2004 -2006 Senior Director, Gastroenterology Medical Affairs, Novartis Pharmaceuticals Corporation @
- 2004 -2004 Head, Gastrointestinal Disease Research @
- 1996 -2004 Neurology and Gastrointestinal Research @
Gareth Hicks Education
- University of Cambridge
PhD (Pharmacology)
1990-1994 - UCL
BSc (Pharmacology)
1987-1990
Gareth Hicks Summary
- Gareth Hicks, based in United States, is currently a Co-founder, CEO and Board Member at Nocicera Therapeutics. Gareth Hicks brings experience from previous roles at Severn Therapeutics, Endosome Therapeutics and Takeda. Gareth Hicks holds a 1990 - 1994 PhD in Pharmacology @ University of Cambridge. Gareth Hicks has 2 emails on RocketReach.
Looking for a different Gareth Hicks?
Find contact details for 700 million professionals.
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co